Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model

Renal Failure

Volumn 32, Issue 7, 2010, Pages 840-848

  Lee, Sul Ra ^a   Lee, Sang Ho ^a   Moon, Ju Young ^a   Park, Ji Yeung ^a   Lee, Dongyoung ^a   Lim, Sung Jig ^a   Jeong, Kyung Hwan ^a   Park, Jae Kyung ^b   Lee, Tae Won ^a   Ihm, Chun Gyoo ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Cell therapy; Chronic renal disease; Mesenchymal stem cells; Remnant kidney model

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; CREATININE; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENGRAFTMENT; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; KIDNEY; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHRECTOMY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SRY GENE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINARY EXCRETION;

ANIMALS; BONE MARROW CELLS; CHRONIC DISEASE; FEMALE; KIDNEY DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77954878735     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.494803     Document Type: Article

References (29)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
2. Dominici M, Le Blank K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.
3. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells. 2008;26:2075-2082.
4. Qian H, Yang H, Xu W, et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int J Mol Med. 2008;22:325-332.
5. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 2009;18:521-529.
6. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15:1759-1804.
7. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31-F42. (Pubitemid 40863570)
8. Ninichuk V, Gross O, Segerer S, et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2007;70:121-129.
9. Alexandre CS, Volpini RA, Shimizu MH, et al. Lineagenegative bone marrow cells protect against chronic renal failure. Stem Cells. 2009;27:682-692.
10. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004;14:1035-1041.
11. Striker GE, Mannik M, Tung MY. Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med. 1979;149:127-136.
12. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-1822.
13. Inoue S, Popp FC, Koehl GE, et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation. 2006;81:1589-1595.
14. Striker GE, Striker LJ. Glomerular cell culture. Lab Invest. 1986;53:181-191.
15. Podjarny E, Bernheim J, Hasdan G, et al. Additive renoprotective effect of candesartan and tetrahydrobiopterin in rats after 5/6 nephrectomy. Nephrol Dial Transplant. 2007;22:1864-1872.
16. Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM Jr, Zatz R. Chronic inhibition of nuclear factor-kappa B attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol. 2006;292:F92-F99.
17. Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol. 2009;29:274-282.
18. Rossi P, Dolci S, Albanesi C, Grimaldi P, Geremia R. Direct evidence that the mouse sex-determining gene Sry is expressed in the somatic cells of male fetal gonads and in the germ cell line in the adult testis. Mol Reprod Dev. 1993;34:369-373.
19. Caldas HC, Fernandes IM, Gerbi F, et al. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc. 2008;40:853-855.
20. Hishikawa K, Fujita T. Stem cells and kidney disease. Hypertens Res. 2006;29:745-749.
21. Kunter U, Rong S, Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006;17:2202-2212.
22. Ostendorf T, Kunter U, Eitner F, et al. VEGF-b mediates glomerular endothelial repair. J Clin Invest. 1999;104:913-923.
23. Schrijvers BF, Flyvbjerg A, Tilton RG, Rasch R, Lameire NH, De Vriese AS. Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron Exp Nephrol. 2005;101:e9-e15.
24. Coimbra TM, Carvalho J, Fattori A, Da Silva CG, Lachat JJ. Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation. Int J Exp Pathol. 1996;77:167-173.
25. Hamar P, Peti-Peterdi J, Rázga Z, Kovács G, Heemann U, Rosivall L. Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney. J Am Soc Nephrol. 1999;10:S234-S238.
26. Choi JJ, Yoo SA, Park SJ, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol. 2008;153:269-276.
27. Du YY, Zhou SH, Zhou T, et al. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy. 2008;10:469-478.
28. Crop MJ, Baan CC, Korevaar SS, et al. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation. 2009;87:896-906.
29. Cavaglieri RC, Martini D, Sogayar MC, Noronha IL. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc. 2009;41:947-951